The Claim
Among patients with confirmed Helicobacter pylori infection, the presence of gastric intestinal metaplasia is not associated with Graves' disease or Hashimoto's thyroiditis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with a confirmed Helicobacter pylori infection, the presence of a precancerous stomach condition called gastric intestinal metaplasia occurs at the same rate regardless of whether the person has Graves' disease or Hashimoto's thyroiditis.
See the scientific wording
The presence of gastric intestinal metaplasia is not associated with either Graves’ disease or Hashimoto’s thyroiditis among patients with confirmed Helicobacter pylori infection, indicating that this pre-cancerous lesion does not differ by autoimmune thyroid status in this population.
A specific type of stomach bacteria injects a protein that triggers long-lasting stomach inflammation and tricks the immune system into attacking the thyroid. This process does not change how often the stomach develops a pre-cancerous lining change, regardless of whether the thyroid is also being attacked by the immune system.
What the research says
1 studyAmong people with a stomach bacteria called H. pylori, having an autoimmune thyroid disease like Graves’ or Hashimoto’s doesn’t make it more or less likely to have a pre-cancerous stomach change called intestinal metaplasia. The study found no connection between the two.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.